跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 464 条关于
“YB1-v3.0”
全部
464
临床试验
297
药物
146
机构
0
资讯
21
3个月前
Salvectors' Oncolytic Bacteria Therapy YB1-X7 Receives Dual IND Clearance in US and China
2个月前
World's First AGI Smart City Clinical Trial Opens Enrollment for Veterans and Mental Health Populations
去年
CB1 Inhibitors Resurface as Potential Obesity Treatment with Improved Safety Profiles
2年前
FDA Modernization Act 3.0 Introduced to Expedite Non-Animal Drug Testing
4个月前
Abbott Receives FDA Clearance for Ultreon 3.0 AI-Powered Coronary Imaging Platform
10个月前
BiomX Secures $3.0 Million Private Placement to Advance Bacteriophage Therapies for Bacterial Infections
去年
Tenon Medical Secures $3.0 Million Through Warrant Transaction to Advance SI Joint Fusion Technology
去年
CB1 Agonist Trial Results Trigger Stock Drop for Corbus and Novo Nordisk
去年
Novo Nordisk's Oral CB1 Blocker Monlunabant Fails in Phase II Obesity Trial
9个月前
Sanofi Secures $1.04 Billion License for ADEL-Y01, Novel Tau-Targeting Alzheimer's Therapy
第 1 页,共 3 页
上一页
下一页